Does adding local salvage ablation therapy provide survival advantage for patients with locally recurrent prostate cancer following radiotherapy? Whole gland salvage ablation post-radiation failure in prostate cancer.

CONCLUSIONS: In select men with recurrent prostate cancer post-radiation, further local treatment may lead to benefits in CSS. These hypothesis-generating findings should ideally be validated in a prospective clinical trial setting. PMID: 33007180 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33007180?dopt=Abstract

Source: Canadian Urological Association Journal - September 27, 2020 Category: Urology & Nephrology Authors: Nair SM, Warner A, Lavi A, Rodrigues G, Chin J Tags: Can Urol Assoc J Source Type: research